AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: It is shown that hyperactivation of key signaling pathways, including the PI3k/AKT, Stat5 and p38 pathways, and expression of short transforming isoform of Cebpa in Gadd45a deficient BM cells may partly account for accelerated CML progression (Figure 6).